Fairness of 3M Earplug Settlement Funding Including Common Stock Transfer To Be Evaluated By MDL, State Court Judges
3M has proposed using common stock to pay for $1 billion of its $6 billion earplug settlement agreement.
3M has proposed using common stock to pay for $1 billion of its $6 billion earplug settlement agreement.
Report decribes a patient who suffered diabetic ketoacidosis that was likely caused by side effects of Tepezza, leading researchers to warn that the thyroid eye disease drug could pose serious risks for diabetes patients
As the latest 3M earplug settlement update is issued by the Court, there remain questions over whether enough veterans will sign onto the deal to finalize the pact, which would average about $24,000 per claim.
Former users allege that Horizon Therapeutics was aware of long-term Tepezza hearing complaints years before a warning label update in July 2023
The deal seeks to prevent Amgen from leveraging its near-monopoly on Tepezza and other Horizon drugs into an overwhelming competitive advantage.
Manufacturer of the thyroid eye disease drug indicates it plans to move to dismiss any Tepezza lawsuits over hearing loss on federal preemption grounds, seeking to delay the work up of individual cases for potential bellwether trials.
Nearly 300,000 hearing loss lawsuits are currently being pursued against 3M Company by veterans who claim they were issued defective earplugs during military service between 2003 and 2015
Florida man indicates the thyroid eye disease drug maker should have warned consumers that side effects of Tepezza may cause permanent hearing loss and ringing in the ears
3M Company reported $6.84 billion losses in latest quarterly report, as the costs of the firefighter foam and earplug hearing loss lawsuits continue to mount.
The conference comes as a growing number of former users continue to file lawsuits over Tepezza hearing loss, alleging that the manufacturer failed to adequately warn about risks associated with the thyroid eye disease treatment.